In silico Antiplasmodial and Anti-inflammatory Activities of Compounds derived from Anogeissus leiocarpus
Keywords:
Malaria, Plasmodium falciparum, in silico, Anogeissus leiocarpusAbstract
Background: Over expression of inflammatory cytokines causes severity of malaria, and due to report of drug resistant strains of Plasmodium species, new and effective antimalarial drugs with anti-inflammatory properties are desirable.
Materials and Methods: The compounds present in acetone leaf and stem bark extracts of Anogeissus leiocarpus were identified by Gas Chromatography-Mass Spectrometry (GC-MS) analysis and assessed for their potentials as antimalarial and anti-inflammatory agents, using in silico methods. The compounds identified were docked against Plasmodium falciparum dihydrofolate reductase (PfDHFR), enoyl acyl carrier protein reductase (PfENR) and hexose transporter 1 (PfHT1), using SwissDock online server and the binding interactions were assessed with Ligplot+ tool. Using the same approach, these compounds were also docked against human inflammatory cytokines; interferon gamma (IFN-γ), tumor necrosis factor-α (TNF-α) and interleukin-12 (IL-12). The ADMET (absorption, distribution, metabolism, excretion, toxicity) profiles and drug-like properties of the promising compounds were investigated using admetSAR. Ten and twenty-one compounds were mined from stem bark and leaf, respectively.
Results: From the molecular docking studies, the lead compounds identified to possess both antiplasmodial and anti-inflammatory effects are oleic acid; cyclopropaneoctanal, 2-octyl-; octadec-9-enoic acid; n-Hexadecanoic acid; tetradecanoic acid; N-Glycylglycine; phytol, acetate; phytol and 9,12-Octadecadienoic acid (Z,Z)- with binding energies ranging from -9.60 to -7.27 Kcal/mol. These compounds bind by hydrogen bonds and hydrophobic interactions to key amino acid residues of the targets. The compounds also showed acceptable ADMET profiles and are predicted to be drug-like.
Conclusion: In- silico analysis of Anogeissus leiocarpus confirms the presence of bioactive anti-plasmodial and anti-inflammatory agents with safe ADMET profile. However, further investigation may be needful for confirmation of these beneficial effects.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 The Nigerian Journal of Immunology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.